How These Five Essential Oils Cool the Burning Pains of Bartonella and Lyme Disease

For people with Bartonella and Lyme disease that struggle with burning pains in their hands and feet
by Greg Lee

Do you know what music teachers say about learning to play an instrument? “Practice, practice, practice.” My daughter is learning to play the clarinet. She is doing well follow along with the notes on the music sheet. Sometimes she enjoys making hilarious squeaks and some really loud honking sounds just for fun.

How is a squeaky, loud clarinet similar to the burning pains of a Bartonella / Lyme infection?

Similar to squeaky clarinet sounds, people with Bartonella and Lyme can have “loud” burning pains in their extremities
Patients diagnosed with Bartonella and Lyme disease often report a wide variety of painful symptoms including: joint pain^[1], muscle pain^[2], lymph node pain, abdominal discomfort^[3], and uncomfortable symptoms of polyneuropathy/nerve damage: weakness, tingling, prickling, awkward gait, and numbness^[4]. One of the most urgent and often debilitating symptoms that people report is burning pain in the hands, feet and extremities^[5]. Burning symptoms are often worse in the morning and may improve over time or with movement. One theory is that nerve damage is an underlying cause of these burning symptoms^[6]. Looking at other illnesses with similar burning pain sensations may provide new insights into relieving these hot, painful symptoms.

In addition to Bartonella, people with a condition called erythromelalgia report similar symptoms of burning pain in their hands and feet
“Erythromelalgia is a rare condition that primarily affects the feet and, less commonly, the hands (extremities). It is characterized by intense, burning pain of affected extremities, severe redness (erythema), and increased skin temperature that may be episodic or almost continuous in nature.^[7]” People with erythromelalgia reported their pain attacks being triggered by heat or exercise and relieved mainly by cooling methods^[8]. A large proportion of these pain attacks often do not involve a specific trigger. An important discovery connects a specific genetic mutation with enhanced pain sensitivity in people with erythromelalgia.

The intensity of burning symptoms in erythromelalgia patients is correlated with a mutation in a gene called SCN9A
The SCN9A gene affects the functioning of sodium channel called NaV1.7^[9]. This channel is a pathway for transmission of pain signals. Genetic mutations affecting NaV1.7 may blunt the ability to sense pain^[10] or dramatically increase pain sensitivity^[11]. Researchers are looking at tarantulas for a possible remedy for relieving the the burning pain sensations.

Green velvet tarantula venom contains a peptide that may help to reduce burning pains by affecting the NaV1.7 channel^[12] In mouse experiments, this peptide was effective a reducing the pain sensations by blocking the NaV1.7 channel. Finding and testing at tarantula-based NaV1.7 medication will likely take years to develop.

What else may help with reducing burning hand and feet pain in people with Lyme disease and Bartonella?

A compound found in essential oils also blocks the pain signals in the NaV1.7 channel
There is a compound called methyl eugenol that was effective in inhibiting nerve signals in NaV1.7 channels in a lab experiment^[13]. In animal studies, this compound has demonstrated anesthetic and the ability to block pain signals^[14]. This compound is approved by the FDA for use as a flavoring agent that can be directly and safely added to food^[15]. Caution: rodent studies on methyl eugenol have produce cancer tumors in their livers^[16]. Processing these oils into a microparticle called a liposome may increase their ability to penetrate into nerve cells to enhance pain relief^[17]. All of these essential oils are classified as GRAS (generally recognized as safe) by the US FDA (Food and Drug Administration).

Burning Pain Relief Essential Oil #1: Sweet Basil
In lab studies, methyl eugenol content in basil essential oil varied from 1.5% – 78% depending upon the country of origin^[18]. Turkish sweet basil had the highest content of methyl eugenol. This essential oil is classified by the FDA as GRAS^[19]. In animal studies, this essential oil demonstrated analgesic effects on chronic non-inflammatory pain such as fibromyalgia^[20] and the ability to block pain signals^[21]. This herb has been used traditionally to treat nerve pain, convulsions and a variety of neurodegenerative disorders^[22]. In addition to basil, bay laurel essential oil has pain relieving properties.

Burning Pain Relief Essential Oil #2: Bay Laurel
This essential oil has been found to contain up to 9% methyl eugenol^[23]. In animal studies, this oil has demonstrated pain relieving effects^[24]. In other studies, bay laurel essential oil inhibits Staphylococcus aureus and it’s biofilms^[25] and Candida species and it’s biofilms^[26]. Bay Laurel essential oil has FDA GRAS status^[27]. In addition to bay laurel, rose essential oil also has pain relieving properties.

Burning Pain Relief Essential Oil #3: Rose
Rose essential oil may contain up to 3.5% methyl eugenol^[28]. In human studies, rose essential oil provided pain relief in patients with dysmenorrhea^[29] and renal colic^[30]. In a lab study, rose oil demonstrated antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and, Staphylococcus aureus^[31]. Rose essential oil has FDA GRAS status^[32]. Clary sage essential oil also contains methyl eugenol.

Burning Pain Relief Essential Oil #4: Clary Sage
Clary sage essential oil may contain up to 2% methyl eugenol. This oil was effective at reduce labor pains in a human study^[33]. A combination of clary sage with other essential oils helped to reduce menstrual cramps^[34]. In lab studies, clary sage essential oil was effective against Staphylococcus clinical strains resistant to antibiotics^[35] and in combination with juniper essential oil demonstrated anti-yeast properties^[36]. Clary sage is classified as FDA GRAS^[37]. Lemon balm essential oil also contains methyl eugenol.

Burning Pain Relief Essential Oil #5: Lemon Balm
Lemon balm essential oil may contain up to 1% methyl eugenol^[38]. In animal studies, this essential oil was effective at reducing neuropathy pain^[39] and inflammation^[40]. Lemon balm oil is also effective against Candida albicans^[41], herpes simplex virus type 1 and type 2^[42], cutaneous leishmaniosis^[43], Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, and Listeria monocytogenes^[44] in lab studies. Lemon balm essential oil is classified at FDA GRAS^[45]. Multiple essential oils may help with reducing how patients feel burning pain by disrupting signals transmitted along the NaV1.7 pathway.

These five essential oils may help to reduce burning pain caused by Bartonella and Lyme disease
People with Lyme disease and Bartonella and Lyme disease that report burning pains in their hands, feet, and extremities may be helped by research into a similar painful illness called erythromelalgia. Just like getting a child to play their instrument at a harmonious level, these essential oils contain a compound called methyl eugenol that may help to reduce the intensity of burning pains by blocking the pain signals along the NaV1.7 pathway. Some of these remedies may also help with reducing inflammation and other types of pain. Processing these essential oils into microparticle liposome remedies may enhance their ability to penetrate inside of nerve cells and improve pain relief. Since formulating essential oils into liposomal remedies requires special knowledge and equipment, work with a Lyme / liposomal literate natural remedy practitioner to develop a customized, safe, and effective treatment plan for your condition.

– Greg

>> Next step: Click here to take our stealthy co-infection quiz to see which tick infections may be causing your symptoms.


P.S. Do you have experiences where remedies or treatments helped you to reduce burning pains from Bartonella and Lyme disease? Tell us about it.

---

^[1] Arvikar, Sheila L., and Allen C. Steere. “Diagnosis and Treatment of Lyme Arthritis.” Infectious Disease Clinics of North America 29, no. 2 (June 2015): 269–80. doi:10.1016/j.idc.2015.02.004. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443866/

^[2] Garakani, Amir, and Andrew G. Mitton. “New-Onset Panic, Depression with Suicidal Thoughts, and Somatic Symptoms in a Patient with a History of Lyme Disease.” Case Reports in Psychiatry 2015 (2015): 457947. doi:10.1155/2015/457947.  https://www.ncbi.nlm.nih.gov/pubmed/25922779

^[3] Mazur-Melewska, Katarzyna, Anna Mania, Paweł Kemnitz, Magdalena Figlerowicz, and Wojciech Służewski. “Cat-Scratch Disease: A Wide Spectrum of Clinical Pictures.” Advances in Dermatology and Allergology/Postȩpy Dermatologii I Alergologii 32, no. 3 (June 2015): 216–20. doi:10.5114/pdia.2014.44014.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495109/

^[4] “Polyneuropathy.” Wikipedia, April 10, 2017. https://en.wikipedia.org/w/index.php?title=Polyneuropathy&oldid=774727139.

^[5] Horowitz, Richard. Why Can’t I Get Better? Solving the Mystery of Lyme and Chronic Disease. Macmillan, 2013.  P. 75.

^[6] “Lyme and Tick-Borne Diseases Research Center.” Accessed April 29, 2017. https://asp.cumc.columbia.edu/lymedisease/askthedr/for_pt/displayanswer1-lyme.asp?Departments=LymeDisease&Controlnumber=4824.

^[7] “Erythromelalgia – NORD (National Organization for Rare Disorders).” NORD (National Organization for Rare Disorders). Accessed April 29, 2017. https://rarediseases.org/rare-diseases/erythromelalgia/.

^[8] McDonnell, Aoibhinn, Betsy Schulman, Zahid Ali, Sulayman D. Dib-Hajj, Fiona Brock, Sonia Cobain, Tina Mainka, Jan Vollert, Sanela Tarabar, and Stephen G. Waxman. “Inherited Erythromelalgia due to Mutations in SCN9A: Natural History, Clinical Phenotype and Somatosensory Profile.” Brain: A Journal of Neurology 139, no. Pt 4 (April 2016): 1052–65. doi:10.1093/brain/aww007.  https://www.ncbi.nlm.nih.gov/pubmed/26920677

^[9] Kim, David Ta, Elsa Rossignol, Kinda Najem, and Luis H. Ospina. “Bilateral Congenital Corneal Anesthesia in a Patient with SCN9A Mutation, Confirmed Primary Erythromelalgia, and Paroxysmal Extreme Pain Disorder.” Journal of AAPOS: The Official Publication of the American Association for Pediatric Ophthalmology and Strabismus 19, no. 5 (October 2015): 478–79. doi:10.1016/j.jaapos.2015.05.015.

^[10] Remacle, Albert G., Sonu Kumar, Khatereh Motamedchaboki, Piotr Cieplak, Swathi Hullugundi, Jennifer Dolkas, Veronica I. Shubayev, and Alex Y. Strongin. “Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-Gated Sodium Channels and Potential Alterations in Pain Signaling.” The Journal of Biological Chemistry 290, no. 38 (September 18, 2015): 22939–44. doi:10.1074/jbc.C115.671107.

^[11] Levinson, Simon R., Songjiang Luo, and Michael A. Henry. “THE ROLE OF SODIUM CHANNELS IN CHRONIC PAIN.” Muscle & Nerve 46, no. 2 (August 2012): 155–65. doi:10.1002/mus.23314.

^[12] Flinspach, M., Q. Xu, A. D. Piekarz, R. Fellows, R. Hagan, A. Gibbs, Y. Liu, et al. “Insensitivity to Pain Induced by a Potent Selective Closed-State Nav1.7 Inhibitor.” Scientific Reports 7 (January 3, 2017): 39662. doi:10.1038/srep39662.

^[13] Wang, Ze-Jun, Boris Tabakoff, Simon R Levinson, and Thomas Heinbockel. “Inhibition of Nav1.7 Channels by Methyl Eugenol as a Mechanism Underlying Its Antinociceptive and Anesthetic Actions.” Acta Pharmacologica Sinica 36, no. 7 (July 2015): 791–99. doi:10.1038/aps.2015.26.  https://www.ncbi.nlm.nih.gov/pubmed/26051112

^[14] Dallmeier, K., and E. A. Carlini. “Anesthetic, Hypothermic, Myorelaxant and Anticonvulsant Effects of Synthetic Eugenol Derivatives and Natural Analogues.” Pharmacology 22, no. 2 (1981): 113–27.  https://www.ncbi.nlm.nih.gov/pubmed/7208593

^[15] “CFR – Code of Federal Regulations Title 21.” Accessed April 29, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?FR=172.515.

^[16] Humans, IARC Working Group on the Evaluation of Carcinogenic Risk to. METHYLEUGENOL. International Agency for Research on Cancer, 2013. https://www.ncbi.nlm.nih.gov/books/NBK373178/.

^[17] Tadicherla, Sujatha, and Brian Berman. “Percutaneous Dermal Drug Delivery for Local Pain Control.” Therapeutics and Clinical Risk Management 2, no. 1 (March 2006): 99–113.

^[18] Pandey, Abhay Kumar, Pooja Singh, and Nijendra Nath Tripathi. “Chemistry and Bioactivities of Essential Oils of Some Ocimum Species: An Overview.” Asian Pacific Journal of Tropical Biomedicine 4, no. 9 (September 2014): 682–94. doi:10.12980/APJTB.4.2014C77.

^[19] “CFR – Code of Federal Regulations Title 21.” Accessed April 30, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.20.

^[20] Nascimento, Simone S., Adriano A. S. Araújo, Renan G. Brito, Mairim R. Serafini, Paula P. Menezes, Josimari M. DeSantana, Waldecy Lucca, et al. “Cyclodextrin-Complexed Ocimum Basilicum Leaves Essential Oil Increases Fos Protein Expression in the Central Nervous System and Produce an Antihyperalgesic Effect in Animal Models for Fibromyalgia.” International Journal of Molecular Sciences 16, no. 1 (December 29, 2014): 547–63. doi:10.3390/ijms16010547.

^[21] Venâncio, Antônio Medeiros, Alexandre Sherlley Onofre, Amintas Figueiredo Lira, Péricles Barreto Alves, Arie Fitzgerald Blank, Angelo Roberto Antoniolli, Murilo Marchioro, Charles dos Santos Estevam, and Brancilene Santos de Araujo. “Chemical Composition, Acute Toxicity, and Antinociceptive Activity of the Essential Oil of a Plant Breeding Cultivar of Basil (Ocimum Basilicum L.).” Planta Medica 77, no. 8 (May 2011): 825–29. doi:10.1055/s-0030-1250607.

^[22] Singh, Varinder, Aditi Kahol, Inder Pal Singh, Isha Saraf, and Richa Shri. “Evaluation of Anti-Amnesic Effect of Extracts of Selected Ocimum Species Using in-Vitro and in-Vivo Models.” Journal of Ethnopharmacology 193 (December 4, 2016): 490–99. doi:10.1016/j.jep.2016.10.026.

^[23] “Essential Oils | Oxford Biosciences.” Accessed April 30, 2017. https://oxfordbiosciences.com/essential-oils/.

^[24] Sayyah, M., G. Saroukhani, A. Peirovi, and M. Kamalinejad. “Analgesic and Anti-Inflammatory Activity of the Leaf Essential Oil of Laurus Nobilis Linn.” Phytotherapy Research: PTR 17, no. 7 (August 2003): 733–36. doi:10.1002/ptr.1197.

^[25] Merghni, A., H. Marzouki, H. Hentati, M. Aouni, and M. Mastouri. “Antibacterial and Antibiofilm Activities of Laurus Nobilis L. Essential Oil against Staphylococcus Aureus Strains Associated with Oral Infections.” Pathologie-Biologie, December 4, 2015. doi:10.1016/j.patbio.2015.10.003.

^[26] Peixoto, Larissa Rangel, Pedro Luiz Rosalen, Gabriela Lacet Silva Ferreira, Irlan Almeida Freires, Fabíola Galbiatti de Carvalho, Lúcio Roberto Castellano, and Ricardo Dias de Castro. “Antifungal Activity, Mode of Action and Anti-Biofilm Effects of Laurus Nobilis Linnaeus Essential Oil against Candida Spp.” Archives of Oral Biology 73 (January 2017): 179–85. doi:10.1016/j.archoralbio.2016.10.013.

^[27] “CFR – Code of Federal Regulations Title 21.” Accessed April 30, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.20.

^[28] “Essential Oils | Oxford Biosciences.” Accessed April 30, 2017. https://oxfordbiosciences.com/essential-oils/.

^[29] Uysal, Murat, Hatice Yılmaz Doğru, Emrah Sapmaz, Ufuk Tas, Bülent Çakmak, Asker Zeki Ozsoy, Fatih Sahin, Safiye Ayan, and Mehmet Esen. “Investigating the Effect of Rose Essential Oil in Patients with Primary Dysmenorrhea.” Complementary Therapies in Clinical Practice 24 (August 2016): 45–49. doi:10.1016/j.ctcp.2016.05.002.

^[30] Ayan, Murat, Ufuk Tas, Erkan Sogut, Mustafa Suren, Levent Gurbuzler, and Feridun Koyuncu. “Investigating the Effect of Aromatherapy in Patients with Renal Colic.” Journal of Alternative and Complementary Medicine (New York, N.Y.) 19, no. 4 (April 2013): 329–33. doi:10.1089/acm.2011.0941.

^[31] Ulusoy, Seyhan, Gülgün Boşgelmez-Tinaz, and Hale Seçilmiş-Canbay. “Tocopherol, Carotene, Phenolic Contents and Antibacterial Properties of Rose Essential Oil, Hydrosol and Absolute.” Current Microbiology 59, no. 5 (November 2009): 554–58. doi:10.1007/s00284-009-9475-y.

^[32] “CFR – Code of Federal Regulations Title 21.” Accessed April 30, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.20.

^[33] Burns, E., C. Blamey, S. J. Ersser, A. J. Lloyd, and L. Barnetson. “The Use of Aromatherapy in Intrapartum Midwifery Practice an Observational Study.” Complementary Therapies in Nursing & Midwifery 6, no. 1 (February 2000): 33–34. doi:10.1054/ctnm.1999.0901.

^[34] Ou, Ming-Chiu, Tsung-Fu Hsu, Andrew C. Lai, Yu-Ting Lin, and Chia-Ching Lin. “Pain Relief Assessment by Aromatic Essential Oil Massage on Outpatients with Primary Dysmenorrhea: A Randomized, Double-Blind Clinical Trial.” The Journal of Obstetrics and Gynaecology Research 38, no. 5 (May 2012): 817–22. doi:10.1111/j.1447-0756.2011.01802.x.

^[35] Sienkiewicz, Monika, Anna Głowacka, Katarzyna Poznańska-Kurowska, Andrzej Kaszuba, Anna Urbaniak, and Edward Kowalczyk. “The Effect of Clary Sage Oil on Staphylococci Responsible for Wound Infections.” Postepy Dermatologii I Alergologii 32, no. 1 (February 2015): 21–26. doi:10.5114/pdia.2014.40957.

^[36] Sienkiewicz, Monika, Anna Głowacka, Katarzyna Poznańska-Kurowska, Andrzej Kaszuba, Anna Urbaniak, and Edward Kowalczyk. “The Effect of Clary Sage Oil on Staphylococci Responsible for Wound Infections.” Postepy Dermatologii I Alergologii 32, no. 1 (February 2015): 21–26. doi:10.5114/pdia.2014.40957.

^[37] “CFR – Code of Federal Regulations Title 21.” Accessed April 30, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.20.

^[38] “Essential Oils | Oxford Biosciences.” Accessed April 30, 2017. https://oxfordbiosciences.com/essential-oils/.

^[39] Hasanein, Parisa, and Hassan Riahi. “Antinociceptive and Antihyperglycemic Effects of Melissa Officinalis Essential Oil in an Experimental Model of Diabetes.” Medical Principles and Practice: International Journal of the Kuwait University, Health Science Centre 24, no. 1 (2015): 47–52. doi:10.1159/000368755.

^[40] Bounihi, Amina, Ghizlane Hajjaj, Rachad Alnamer, Yahia Cherrah, and Amina Zellou. “In Vivo Potential Anti-Inflammatory Activity of Melissa Officinalis L. Essential Oil.” Advances in Pharmacological Sciences 2013 (2013). doi:10.1155/2013/101759.

^[41] Hăncianu, Monica, Ana Clara Aprotosoaie, Elvira Gille, Antonia Poiată, Cristina Tuchiluş, A. Spac, and Ursula Stănescu. “Chemical Composition and in Vitro Antimicrobial Activity of Essential Oil of Melissa Officinalis L. from Romania.” Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi 112, no. 3 (September 2008): 843–47.

^[42] Schnitzler, P., A. Schuhmacher, A. Astani, and Jürgen Reichling. “Melissa Officinalis Oil Affects Infectivity of Enveloped Herpesviruses.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 15, no. 9 (September 2008): 734–40. doi:10.1016/j.phymed.2008.04.018.

^[43] Andrade, Milene Aparecida, Clênia Dos Santos Azevedo, Flávia Nader Motta, Maria Lucília Dos Santos, Camila Lasse Silva, Jaime Martins de Santana, and Izabela M. D. Bastos. “Essential Oils: In Vitro Activity against Leishmania Amazonensis, Cytotoxicity and Chemical Composition.” BMC Complementary and Alternative Medicine 16, no. 1 (November 8, 2016): 444. doi:10.1186/s12906-016-1401-9.

^[44] Abdellatif, Fahima, Hadjira Boudjella, Abdelghani Zitouni, and Aicha Hassani. “Chemical Composition and Antimicrobial Activity of the Essential Oil from Leaves of Algerian Melissa Officinalis L.” EXCLI Journal 13 (July 17, 2014): 772–81.

^[45] “CFR – Code of Federal Regulations Title 21.” Accessed April 30, 2017. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.20.

DISCLAIMER:-

The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient-practitioner relationship, and should not be used as a substitute for professional diagnosis and treatment.

Please consult your health care provider, or contact the Two Frogs Healing Center for an appointment, before making any healthcare decisions or for guidance about a specific medical condition. The Two Frogs Healing Center expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. The Two Frogs Healing Center does not endorse specifically any test, treatment, or procedure mentioned on the site.

By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by the Two Frogs Healing Center. If you do not agree to the foregoing terms and conditions, you should not enter this site.